Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Carl Icahn, SkyBridge Capital, Xeris Pharmaceuticals Inc (XERS), Legacy Reserves LP Unit (LGCY), Pershing Gold Corp (PGLC), and More

Activist Investor Icahn Raises Stake in Oil Producer Energen (Reuters)
(Reuters) – Activist investor Carl Icahn boosted his stake in Energen Corp (EGN.N), a filing showed on Tuesday, as he eyes a potential takeover of the oil and gas producer. In May, hedge fund manager Keith Meister of Corvex Management and Icahn said they may try to buy the producer, which has operations in the prolific Permian Basin of Texas and New Mexico. Icahn now owns 4.3 percent of the company’s shares, up from 3.8 percent last week, according to the filing. Corvex, which is Energen’s second largest shareholder with an 8 percent stake, sold 2 million shares in the company to Icahn last month and granted him an option to buy another 2 million shares.

Scaramucci’s SkyBridge Sues Premium Point Investments (Reuters)
(Reuters) – SkyBridge Capital II LLC said on Monday it was suing Premium Point Investments LP, claiming it lost nearly $80 million because the investment service inflated the value of its hedge fund assets. SkyBridge Capital, a hedge fund investment firm founded by U.S. President Donald Trump’s former aide Anthony Scaramucci, claims that Premium Point overstated its hedge funds’ valuations by $200 million using false broker quotes that artificially inflated the prices of bonds.

buy, sell, sale, trading, market, business, stock, trade, fund,

Ismagilov/shutterstock.com

Reviewing Bill Ackman’s Q1 Trading Activity: Sells Nike and Howard Hughes (Benzinga)
The hedge fund underperformed the market in Q1 as revealed in its recent 13F filing with the SEC. I take a closer look at Pershing Square‘s $4.8 billion portfolio and current stock holdings below. Pershing Square’s Largest Holdings: On May 15th, Bill Ackman‘s firm Pershing Square filed its quarterly Form 13F regulatory filing. I reviewed the filing to gain a glimpse into the firm’s large portfolio. Pershing Square’s stock portfolio totals $4.8 billion according to the latest filing. The list value of stock holdings is down -17.7 percent when compared to the last quarter. As a benchmark, the S&P 500 was down 1.2 percent over the same period.

Hedge-Fund Star Sundheim Lures Piles of Cash on His Own Terms (Bloomberg)
(Bloomberg) — For Dan Sundheim, who starts trading outside capital at his new hedge fund in mid-July, it might as well be 2007. That’s when hedge fund managers dominated Wall Street. They could charge high fees, impose long lock-ups on capital and afford to be discerning about which investors they allowed into their funds. Then came the financial crisis and a decade of low returns and client defections. Most startups barely raised any money.

Insider Buying: Xeris Pharmaceuticals Inc (XERS) Major Shareholder Buys 150,000 Shares of Stock (MaconDaily.com)
Xeris Pharmaceuticals Inc (NASDAQ:XERS) major shareholder Palmetto Partners, Ltd. purchased 150,000 shares of the stock in a transaction dated Monday, June 25th. The shares were bought at an average cost of $15.00 per share, for a total transaction of $2,250,000.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.

Insider Buying: Resonant Inc (RESN) Director Acquires 100,000 Shares of Stock (TheLincolnianOnline.com)
Resonant Inc (NASDAQ:RESN) Director Michael J. Fox purchased 100,000 shares of the business’s stock in a transaction dated Friday, June 15th. The stock was bought at an average price of $5.61 per share, for a total transaction of $561,000.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Insider Buying: Legacy Reserves LP Unit (LGCY) Major Shareholder Acquires 74,076 Shares of Stock (TheEnterpriseLeader.com)
Legacy Reserves LP Unit (NASDAQ:LGCY) major shareholder Baines Creek Capital, Llc bought 74,076 shares of the firm’s stock in a transaction on Friday, June 15th. The stock was acquired at an average cost of $6.00 per share, with a total value of $444,456.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission.

Insider Buying: Pershing Gold Corp (PGLC) Director Acquires 125,000 Shares of Stock (TheLincolnianOnline.com)
Pershing Gold Corp (NASDAQ:PGLC) Director Barry C. Honig bought 125,000 shares of the company’s stock in a transaction on Friday, June 15th. The shares were acquired at an average price of $2.00 per share, for a total transaction of $250,000.00. Following the transaction, the director now directly owns 2,395,600 shares in the company, valued at approximately $4,791,200. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Insider Buying: Electrocore LLC (ECOR) Major Shareholder Purchases 166,666 Shares of Stock (MareaInformativa.com)
Electrocore LLC (NASDAQ:ECOR) major shareholder Global Health Innovation Merck purchased 166,666 shares of the business’s stock in a transaction that occurred on Thursday, June 21st. The shares were purchased at an average cost of $15.00 per share, with a total value of $2,499,990.00. The transaction was disclosed in a filing with the Securities & Exchange Commission.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.